NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novo Nordisk A/S ("Novo Nordisk A/S") (NYSE:NVO) concerning possible violations of federal securities laws. On December 20, 2024, Novo issued a press release announcing the below-expected results of their "REDEFINE 1" […]
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Visa Inc. (NYSE:V) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/visa-inc-lawsuit-submission-form?prid=123912&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bioage-labs-inc-lawsuit-submission-form?prid=123906&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Zeta Global Holdings Corp. (NYSE:ZETA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zeta-global-holdings-corp-lawsuit-submission-form-2?prid=123917&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=123915&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Match Group, Inc. (NASDAQ:MTCH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/match-group-inc-lawsuit-submission-form?prid=123909&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Keros Therapeutics, Inc. ("Keros Therapeutics, Inc.") (NASDAQ:KROS) concerning possible violations of federal securities laws. Keros issued a press release on December 12, 2024, "announc[ing] that it has voluntarily halted dosing in the
LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Rapid7, Inc. ("Rapid7" or "the Company") (NASDAQ:RPD) for potential breaches of fiduciary duty on the part of its directors and management. The investigation
LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Carvana Co. ("Carvana" or "the Company") (NYSE:CVNA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or